Paricasitol as a VDR agonist can inhibit ferroptosis by activating VDR/Nrf2/HO‐1 signaling pathway in DN, which effectively attenuates iron deposition in renal tubular epithelial cells and renal damage after diabetic injury [82]. Here, HMOX1 is linked to liver dysplastic nodule.